Skip to main content
Erschienen in:

30.09.2023 | Original article

Association of epilepsy with neuroimaging patterns in children with cerebral palsy

verfasst von: Mehmet Akif Kilic, Edibe Pembegul Yildiz, Fulya Kurekci, Orhan Coskun, Meryem Cura, Ridvan Avci, Hulya Maras Genc

Erschienen in: Acta Neurologica Belgica | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Abstract

Objectives

In this study, we examined whether epilepsy and drug-resistant epilepsy are associated with neuroimaging findings in children with cerebral palsy (CP).

Methods

Magnetic resonance imaging classification system (MRICS) proposed by Surveillance of Cerebral Palsy in Europe (SCPE) was used for classification of different MRI patterns in patients with cerebral palsy. We reviewed the brain MRI scans and medical records of children with CP who were followed-up in our clinic between 2019 and 2023. Patients were divided into three categories: CP without epilepsy, CP with controlled epilepsy and CP with DRE. MRI patterns were grouped as maldevelopments, predominant white matter injury, predominant gray matter injury, miscellaneous (delayed myelination, cerebral atrophy, cerebellar atrophy, brainstem lesions and calcifications, lesions that were not classified under any other group) and normal according to MRICS of the SCPE.

Results

There were 325 CP patients. The most common MRI patterns were predominant white matter injury (47.6%) and gray matter injury (23.8%). There was a 1.5-fold reduction in the risk of epilepsy in patients with predominant white matter injury (OR = 1.54, 95% CI 1.23–1.94). In contrast, children in the miscellaneous group had significantly higher risks of epilepsy (p < 0.001), and we were able to determine that miscellaneous findings increased the risk by 1.8 times (OR = 1.77, 95% CI 1.47–2.12).

Conclusion

In conclusion, more than half of the children with CP had epilepsy, 40.7% of whom had DRE. On MRI, miscellaneous findings may indicate a poor prognosis for epilepsy, while predominant white matter injury may indicate a good outcome. Children with CP, especially those with miscellaneous findings on MRI, should be closely monitored for epilepsy development.
Literatur
1.
Zurück zum Zitat Michael-Asalu A, Taylor G, Cmpbell H, Lelea LL, Kirby RS (2019) Cerebral palsy: diagnosis, epidemiology, genetics, and clinical update. Adv Pediatr 334:189–208CrossRef Michael-Asalu A, Taylor G, Cmpbell H, Lelea LL, Kirby RS (2019) Cerebral palsy: diagnosis, epidemiology, genetics, and clinical update. Adv Pediatr 334:189–208CrossRef
2.
Zurück zum Zitat Sadowska M, Sarecka-Hujar B, Kopyta I (2020) Cerebral palsy: current opinions on definition, epidemiology, risk factors, classification and treatment options. Neuropsychiatr Dis Treat 16:1505–1518CrossRefPubMedPubMedCentral Sadowska M, Sarecka-Hujar B, Kopyta I (2020) Cerebral palsy: current opinions on definition, epidemiology, risk factors, classification and treatment options. Neuropsychiatr Dis Treat 16:1505–1518CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Ashwal S, Russman BS, Blasco PA, Miller G, Sandler A, Shevell M et al (2004) Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 62:851–863CrossRefPubMed Ashwal S, Russman BS, Blasco PA, Miller G, Sandler A, Shevell M et al (2004) Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 62:851–863CrossRefPubMed
4.
Zurück zum Zitat Graham HK, Rosenbaum P, Paneth N, Dan B, Lin JP, Damiano DL et al (2016) Cerebral palsy. Nat Rev Dis Primers 2:15082CrossRefPubMed Graham HK, Rosenbaum P, Paneth N, Dan B, Lin JP, Damiano DL et al (2016) Cerebral palsy. Nat Rev Dis Primers 2:15082CrossRefPubMed
5.
Zurück zum Zitat Hadjipanayis A, Hadjichristodoulou C, Youroukos S (1997) Epilepsy in patients with cerebral palsy. Dev Med Child Neurol 39(10):659–663CrossRefPubMed Hadjipanayis A, Hadjichristodoulou C, Youroukos S (1997) Epilepsy in patients with cerebral palsy. Dev Med Child Neurol 39(10):659–663CrossRefPubMed
6.
Zurück zum Zitat Hollung SJ, Bakken IJ, Vik T, Lydersen S, Wiik R, Aaberg KM et al (2020) Comorbidities in cerebral palsy: a patient registry study. Dev Med Child Neurol 62(1):97–103CrossRefPubMed Hollung SJ, Bakken IJ, Vik T, Lydersen S, Wiik R, Aaberg KM et al (2020) Comorbidities in cerebral palsy: a patient registry study. Dev Med Child Neurol 62(1):97–103CrossRefPubMed
7.
Zurück zum Zitat Kwong KL, Wong SN, So KT (1998) Epilepsy in children with cerebral palsy. Pediatr Neurol 19(1):31–36CrossRefPubMed Kwong KL, Wong SN, So KT (1998) Epilepsy in children with cerebral palsy. Pediatr Neurol 19(1):31–36CrossRefPubMed
8.
Zurück zum Zitat Pahlman M, Gillberg C, Himmelmann K (2019) One-third of school-aged children with cerebral palsy have neuropsychiatric impairments in a population-based study. Acta Paediatr 108(11):2048–2055CrossRefPubMed Pahlman M, Gillberg C, Himmelmann K (2019) One-third of school-aged children with cerebral palsy have neuropsychiatric impairments in a population-based study. Acta Paediatr 108(11):2048–2055CrossRefPubMed
9.
Zurück zum Zitat Sellier E, Uldall P, Calado E, Sigurdardottir S, Torrioli MG, Platt MJ et al (2012) Epilepsy and cerebral palsy: characteristics and trends in children born in 1976–1998. Eur J Paediatr Neurol 16(1):48–55CrossRefPubMed Sellier E, Uldall P, Calado E, Sigurdardottir S, Torrioli MG, Platt MJ et al (2012) Epilepsy and cerebral palsy: characteristics and trends in children born in 1976–1998. Eur J Paediatr Neurol 16(1):48–55CrossRefPubMed
10.
Zurück zum Zitat Sadowska M, Sarecka-Hujar B, Kopyta I (2020) Evaluation of risk factors for epilepsy in pediatric patients with cerebral palsy. Brain Sci 10(8):481CrossRefPubMedPubMedCentral Sadowska M, Sarecka-Hujar B, Kopyta I (2020) Evaluation of risk factors for epilepsy in pediatric patients with cerebral palsy. Brain Sci 10(8):481CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Mert GG, Incecik F, Altunbasak S, Herguner O, Mert MK, Kiris N et al (2011) Factors affecting epilepsy development and epilepsy prognosis in cerebral palsy. Pediatr Neurol 45:89–94CrossRefPubMed Mert GG, Incecik F, Altunbasak S, Herguner O, Mert MK, Kiris N et al (2011) Factors affecting epilepsy development and epilepsy prognosis in cerebral palsy. Pediatr Neurol 45:89–94CrossRefPubMed
12.
Zurück zum Zitat Kulak W, Sobaniec W (2003) Risk factors and prognosis of epilepsy in children with cerebral palsy in north-eastern Poland. Brain Dev 27:499–506CrossRef Kulak W, Sobaniec W (2003) Risk factors and prognosis of epilepsy in children with cerebral palsy in north-eastern Poland. Brain Dev 27:499–506CrossRef
13.
Zurück zum Zitat Mohammadzadeh P, Nazarbaghi S (2022) The prevalence of drug-resistant-epilepsy and its associated factors in patients with epilepsy. Clin Neurol and Neurosurg 213:107086CrossRef Mohammadzadeh P, Nazarbaghi S (2022) The prevalence of drug-resistant-epilepsy and its associated factors in patients with epilepsy. Clin Neurol and Neurosurg 213:107086CrossRef
14.
Zurück zum Zitat Carlsson M, Olsson I, Hagberg G, Beckung E (2008) Behavior in children with cerebral palsy with and without epilepsy. Dev Med Child Neurol 50:784–789CrossRefPubMed Carlsson M, Olsson I, Hagberg G, Beckung E (2008) Behavior in children with cerebral palsy with and without epilepsy. Dev Med Child Neurol 50:784–789CrossRefPubMed
15.
Zurück zum Zitat Sander JW (2005) Ultimate success in epilepsy–the patient’s perspective. Eur J Neurol 12(Suppl 4):3–11CrossRefPubMed Sander JW (2005) Ultimate success in epilepsy–the patient’s perspective. Eur J Neurol 12(Suppl 4):3–11CrossRefPubMed
16.
Zurück zum Zitat Himmelmann K, Horber V, De La Cruz J, Horridge K, Mejaski-Bosnjak V, Hollody K et al (2017) MRI classification system (MRICS) for children with cerebral palsy: development, reliability, and recommendations. Dev Med Child Neurol 59(1):57–64CrossRefPubMed Himmelmann K, Horber V, De La Cruz J, Horridge K, Mejaski-Bosnjak V, Hollody K et al (2017) MRI classification system (MRICS) for children with cerebral palsy: development, reliability, and recommendations. Dev Med Child Neurol 59(1):57–64CrossRefPubMed
17.
Zurück zum Zitat Krägeloh-Mann I, Horber V (2007) The role of magnetic resonance imaging in elucidating the pathogenesis of cerebral palsy: a systematic review. Dev Med Child Neurol 49(2):144–151CrossRefPubMed Krägeloh-Mann I, Horber V (2007) The role of magnetic resonance imaging in elucidating the pathogenesis of cerebral palsy: a systematic review. Dev Med Child Neurol 49(2):144–151CrossRefPubMed
18.
Zurück zum Zitat Towsley K, Shevell MI, Dagenais L, REPACQ Consortium (2011) Population-based study of neuroimaging findings in children with cerebral palsy. Eur J Paediatr Neurol 15:29–35CrossRefPubMed Towsley K, Shevell MI, Dagenais L, REPACQ Consortium (2011) Population-based study of neuroimaging findings in children with cerebral palsy. Eur J Paediatr Neurol 15:29–35CrossRefPubMed
19.
Zurück zum Zitat Korzeniewski SJ, Birbeck G, DeLano MC, Potchen MJ, Paneth N (2008) A systematic review of neuroimaging for cerebral palsy. J Child Neurol 23:216–227CrossRefPubMed Korzeniewski SJ, Birbeck G, DeLano MC, Potchen MJ, Paneth N (2008) A systematic review of neuroimaging for cerebral palsy. J Child Neurol 23:216–227CrossRefPubMed
20.
Zurück zum Zitat Novak I, Morgan C, Adde L, Blackman J, Boyd RN, Brunstrom-Hernandez J et al (2017) Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment. JAMA Pediatr 171:897–907CrossRefPubMedPubMedCentral Novak I, Morgan C, Adde L, Blackman J, Boyd RN, Brunstrom-Hernandez J et al (2017) Early, accurate diagnosis and early intervention in cerebral palsy: advances in diagnosis and treatment. JAMA Pediatr 171:897–907CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Liptak GS, Murphy NA (2011) Providing a primary care medical home for children and youth with cerebral palsy. Pediatrics 128:e1321–e1329CrossRefPubMed Liptak GS, Murphy NA (2011) Providing a primary care medical home for children and youth with cerebral palsy. Pediatrics 128:e1321–e1329CrossRefPubMed
22.
Zurück zum Zitat Korzeniewski SJ, Slaughter J, Lenski M, Haak P, Paneth N et al (2018) The complex aetiology of cerebral palsy. Nat Rev Neurol 14:528–543CrossRefPubMed Korzeniewski SJ, Slaughter J, Lenski M, Haak P, Paneth N et al (2018) The complex aetiology of cerebral palsy. Nat Rev Neurol 14:528–543CrossRefPubMed
23.
Zurück zum Zitat Reid SM, Dagia CD, Ditchfield MR, Carlin JB, Meehan EM, Reddihough DS (2013) An Australian population study of factors associated with MRI patterns in cerebral palsy. Dev Med Child Neurol 56:178–184CrossRefPubMed Reid SM, Dagia CD, Ditchfield MR, Carlin JB, Meehan EM, Reddihough DS (2013) An Australian population study of factors associated with MRI patterns in cerebral palsy. Dev Med Child Neurol 56:178–184CrossRefPubMed
24.
Zurück zum Zitat Numata Y, Onuma A, Kobayashi Y, Sato-Shirai I, Tanaka S, Kobayashi S et al (2012) Brain magnetic resonance imaging and motor and intellectual functioning in 86 patients born at term with spastic diplegia. Dev Med Child Neurol 55:167–172CrossRefPubMed Numata Y, Onuma A, Kobayashi Y, Sato-Shirai I, Tanaka S, Kobayashi S et al (2012) Brain magnetic resonance imaging and motor and intellectual functioning in 86 patients born at term with spastic diplegia. Dev Med Child Neurol 55:167–172CrossRefPubMed
25.
Zurück zum Zitat Horber V, Sellier E, Horridge K, Rackauskaite G, Andersen GL, Virella D (2020) The origin of the cerebral palsies: contribution of population-based neuroimaging data. Neuropediatrics 51(2):113–119CrossRefPubMed Horber V, Sellier E, Horridge K, Rackauskaite G, Andersen GL, Virella D (2020) The origin of the cerebral palsies: contribution of population-based neuroimaging data. Neuropediatrics 51(2):113–119CrossRefPubMed
26.
Zurück zum Zitat Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CHE et al (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55:475–482CrossRefPubMed Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CHE et al (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55:475–482CrossRefPubMed
27.
Zurück zum Zitat Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G et al (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51(6):1069–1077CrossRefPubMed Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G et al (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51(6):1069–1077CrossRefPubMed
28.
Zurück zum Zitat Téllez-Zenteno JF, Hernández-Ronquillo L, Buckley S, Zahagun R, Rizvi S (2014) A validation of the new dfinition of drug-resistant epilepsy by the International League Against Epilepsy. Epilepsia 55(6):829–834CrossRefPubMed Téllez-Zenteno JF, Hernández-Ronquillo L, Buckley S, Zahagun R, Rizvi S (2014) A validation of the new dfinition of drug-resistant epilepsy by the International League Against Epilepsy. Epilepsia 55(6):829–834CrossRefPubMed
29.
Zurück zum Zitat Laxer KD, Trinka E, Hirsch LJ, Cendes F, Langfitt J, Delanty N et al (2014) The consequences of refractory epilepsy and its treatment. Epilepsy Behav 37:59–70CrossRefPubMed Laxer KD, Trinka E, Hirsch LJ, Cendes F, Langfitt J, Delanty N et al (2014) The consequences of refractory epilepsy and its treatment. Epilepsy Behav 37:59–70CrossRefPubMed
30.
Zurück zum Zitat Löscher W, Potschka H, Sisodiya SM, Vezzani A (2020) Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options. Pharmacol Rev 72(3):606–638CrossRefPubMedPubMedCentral Löscher W, Potschka H, Sisodiya SM, Vezzani A (2020) Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options. Pharmacol Rev 72(3):606–638CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Zafeiriou DI, Kontopoulos EE, Tsikoulas I (1999) Characteristics and prognosis of epilepsy in children with cerebral palsy. J Child Neurol 14:289–294CrossRefPubMed Zafeiriou DI, Kontopoulos EE, Tsikoulas I (1999) Characteristics and prognosis of epilepsy in children with cerebral palsy. J Child Neurol 14:289–294CrossRefPubMed
32.
Zurück zum Zitat Hanci F, Türay S, Dilek M, Kabakuş N (2020) Epilepsy and drug-resistant epilepsy in children with cerebral palsy: a retrospective observational study. Epilepsy Behav 112:107357CrossRefPubMed Hanci F, Türay S, Dilek M, Kabakuş N (2020) Epilepsy and drug-resistant epilepsy in children with cerebral palsy: a retrospective observational study. Epilepsy Behav 112:107357CrossRefPubMed
33.
Zurück zum Zitat Tokatly Latzer I, Blumovich A, Sagi L, Uliel-Sibony S, Fattal-Valevski A (2020) Prediction of drug-resistant eilepsy in children with cerebral palsy. J Child Neurol 35(3):187–194CrossRefPubMed Tokatly Latzer I, Blumovich A, Sagi L, Uliel-Sibony S, Fattal-Valevski A (2020) Prediction of drug-resistant eilepsy in children with cerebral palsy. J Child Neurol 35(3):187–194CrossRefPubMed
34.
Zurück zum Zitat Nagy E, Herbert Z, Péter I, Csorba E, Skobrák A, Farkas N et al (2020) The usefulness of MRI classification system (MRICS) in a cerebral palsy cohort. Acta Paediatr 109(12):2783–2788CrossRefPubMed Nagy E, Herbert Z, Péter I, Csorba E, Skobrák A, Farkas N et al (2020) The usefulness of MRI classification system (MRICS) in a cerebral palsy cohort. Acta Paediatr 109(12):2783–2788CrossRefPubMed
35.
Zurück zum Zitat Himmelmann K, Horber V, Sellier E, De la Cruz J, Papavasiliou A, Krägeloh-Mann I, Surveillance of Cerebral Palsy in Europe (SCPE) Collaboration (2021) Neuroimaging patterns and function in cerebral palsy-application of an MRI classification. Front Neurol 11:617740CrossRefPubMedPubMedCentral Himmelmann K, Horber V, Sellier E, De la Cruz J, Papavasiliou A, Krägeloh-Mann I, Surveillance of Cerebral Palsy in Europe (SCPE) Collaboration (2021) Neuroimaging patterns and function in cerebral palsy-application of an MRI classification. Front Neurol 11:617740CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Carlsson M, Hagberg G, Olsson I (2003) Clinical and aetiological aspects of epilepsy in children with cerebral palsy. Dev Med Child Neurol 45(6):371–376CrossRefPubMed Carlsson M, Hagberg G, Olsson I (2003) Clinical and aetiological aspects of epilepsy in children with cerebral palsy. Dev Med Child Neurol 45(6):371–376CrossRefPubMed
37.
Zurück zum Zitat Horber V, Grasshoff U, Sellier E, Arnaud C, Krägeloh-Mann I, Himmelmann K (2021) The role of neuroimaging and genetic analysis in the diagnosis of children with cerebral palsy. Front Neurol 11:628075CrossRefPubMedPubMedCentral Horber V, Grasshoff U, Sellier E, Arnaud C, Krägeloh-Mann I, Himmelmann K (2021) The role of neuroimaging and genetic analysis in the diagnosis of children with cerebral palsy. Front Neurol 11:628075CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Perucca P, Bahlo M, Berkovic SF (2020) The genetics of epilepsy. Annu Rev Genomics Hum Genet 21:205–230CrossRefPubMed Perucca P, Bahlo M, Berkovic SF (2020) The genetics of epilepsy. Annu Rev Genomics Hum Genet 21:205–230CrossRefPubMed
Metadaten
Titel
Association of epilepsy with neuroimaging patterns in children with cerebral palsy
verfasst von
Mehmet Akif Kilic
Edibe Pembegul Yildiz
Fulya Kurekci
Orhan Coskun
Meryem Cura
Ridvan Avci
Hulya Maras Genc
Publikationsdatum
30.09.2023
Verlag
Springer International Publishing
Erschienen in
Acta Neurologica Belgica / Ausgabe 2/2024
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI
https://doi.org/10.1007/s13760-023-02385-w

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Neurologie

„Wir wollen die Bedeutung von Gen- und Umwelteinflüssen besser verstehen“

Eine Mutation in einem einzelnen Gen kann bei Mäusen eine Art Bipolarstörung auslösen. PD Dr. Jan Deussing vom Max-Planck-Institut für Psychiatrie in München sieht in solchen Tiermodellen eine Möglichkeit, den Ursachen der Erkrankung auf den Grund zu gehen.

Suizidassistenz erhöht Suizidzahlen: Aktuelle Ergebnisse der geplanten S3-Leitlinie

Erstmals wird in Deutschland eine S3-Leitlinie zum Thema Suizidalität erarbeitet. Ziel ist es, die Versorgung in suizidalen Krisen durch einheitliche Standards zu verbessern. Erste Ergebnisse der bisherigen Leitlinienarbeit wurden auf dem DGPPN-Kongress vorgestellt.

Kaum Vorteile durch intraarterielle Lyse während Thrombektomie

Nach der Thrombektomie kleinere Fragmente über eine intraarterielle Lyse auflösen – dies könnte die Schlaganfalltherapie verbessern. Zwei aktuelle Studien ergeben für die periprozedurale Lyse jedoch keine großen Vorteile. Die Frage, wie viel sie nützt, bleibt weiter offen.

Nasenstimulation lindert chronische Migräne

Wird die Naseninnenseite durch Vibrationen stimuliert, kann dies offenbar die Zahl der Migränetage von Menschen mit chronischer Migräne deutlich senken. Darauf deuten die Resultate einer randomisiert-kontrollierten deutsch-finnischen Untersuchung.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.